Litcius/Paper detail

Diagnostics, therapeutics and RET inhibitor resistance for RET fusion–positive non-small cell lung cancers and future perspectives

Chang Lu, Qing Zhou

2021Cancer Treatment Reviews27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAcquired resistanceCompendiumClinical trialTargeted therapyLung cancerBioinformaticsOncologyInternal medicineCancerBiologyHistoryArchaeologyLung Cancer Treatments and MutationsLung Cancer Research StudiesRNA modifications and cancer
Diagnostics, therapeutics and RET inhibitor resistance for RET fusion–positive non-small cell lung cancers and future perspectives | Litcius